Novo Nordisk Surges on 41% Obesity Sales Growth and Strategic MASH Pipeline Expansion, Despite DKK 9 Billion Restructuring Hit image
3 min read

Novo Nordisk Surges on 41% Obesity Sales Growth and Strategic MASH Pipeline Expansion, Despite DKK 9 Billion Restructuring Hit

Pharm'Up
Novo Nordisk A/S, the Danish pharmaceutical giant, today released a robust financial report for the first nine...
Read More Read more about Novo Nordisk Surges on 41% Obesity Sales Growth and Strategic MASH Pipeline Expansion, Despite DKK 9 Billion Restructuring Hit
Merck Secures $700 Million from Blackstone to Accelerate Development of Next-Generation TROP2 ADC, Sacituzumab Tirumotecan image
3 min read

Merck Secures $700 Million from Blackstone to Accelerate Development of Next-Generation TROP2 ADC, Sacituzumab Tirumotecan

Pharm'Up
A significant financial collaboration has been finalized to dramatically accelerate the clinical development of sacituzumab tirumotecan (sac-TMT),...
Read More Read more about Merck Secures $700 Million from Blackstone to Accelerate Development of Next-Generation TROP2 ADC, Sacituzumab Tirumotecan
NATCO Pharma Wins Legal Battle Against Roche to Launch Affordable Risdiplam for Spinal Muscular Atrophy in India image
2 min read

NATCO Pharma Wins Legal Battle Against Roche to Launch Affordable Risdiplam for Spinal Muscular Atrophy in India

Pharm'Up
NATCO Pharma Limited announced a major legal victory in its ongoing patent dispute with pharmaceutical giant Roche....
Read More Read more about NATCO Pharma Wins Legal Battle Against Roche to Launch Affordable Risdiplam for Spinal Muscular Atrophy in India
AstraZeneca Strikes Landmark Deal with Trump Administration Cuts U.S. Drug Prices, Commits $50 Billion to Domestic Manufacturing image
2 min read

AstraZeneca Strikes Landmark Deal with Trump Administration Cuts U.S. Drug Prices, Commits $50 Billion to Domestic Manufacturing

Pharm'Up
AstraZeneca has announced a landmark agreement with President Donald J. Trump’s administration aimed at significantly reducing prescription...
Read More Read more about AstraZeneca Strikes Landmark Deal with Trump Administration Cuts U.S. Drug Prices, Commits $50 Billion to Domestic Manufacturing
Lilly’s Oral GLP-1, Orforglipron, Achieves Superior Glycemic Control and Weight Loss in Head-to-Head Phase 3 Trials image
2 min read

Lilly’s Oral GLP-1, Orforglipron, Achieves Superior Glycemic Control and Weight Loss in Head-to-Head Phase 3 Trials

Pharm'Up
Eli Lilly and Company announced positive topline results from two pivotal Phase 3 trials, ACHIEVE-2 and ACHIEVE-5,...
Read More Read more about Lilly’s Oral GLP-1, Orforglipron, Achieves Superior Glycemic Control and Weight Loss in Head-to-Head Phase 3 Trials
Eli Lilly Partners with Cipla to Launch Second Brand of Tirzepatide (Yurpeak®) for Diabetes and Obesity in India image
2 min read

Eli Lilly Partners with Cipla to Launch Second Brand of Tirzepatide (Yurpeak®) for Diabetes and Obesity in India

Pharm'Up
Eli Lilly and Cipla Limited announced a commercial agreement to distribute and promote tirzepatide in India under...
Read More Read more about Eli Lilly Partners with Cipla to Launch Second Brand of Tirzepatide (Yurpeak®) for Diabetes and Obesity in India

Read These Too

Pharmup 21
2 min read

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up